Zobrazeno 1 - 10
of 372
pro vyhledávání: '"IRIE, Toshiaki"'
Publikováno v:
In Nuclear Medicine and Biology July 2013 40(5):664-669
Autor:
Sato, Koichi, Fukushi, Kiyoshi, Shinotoh, Hitoshi, Shimada, Hitoshi, Tanaka, Noriko, Hirano, Shigeki, Irie, Toshiaki
Publikováno v:
In NeuroImage 15 February 2012 59(4):3149-3158
Autor:
Ohya, Tomoyuki, Okamura, Toshimitsu, Nagai, Yuji, Fukushi, Kiyoshi, Irie, Toshiaki, Suhara, Tetsuya, Zhang, Ming-Rong, Fukumura, Toshimitsu, Kikuchi, Tatsuya
Publikováno v:
In NeuroImage 1 June 2011 56(3):1105-1110
Autor:
Miyoshi, Michie, Shinotoh, Hitoshi, Wszolek, Zbigniew K., Strongosky, Audrey J., Shimada, Hitoshi, Arakawa, Ryosuke, Higuchi, Makoto, Ikoma, Yoko, Yasuno, Fumihiko, Fukushi, Kiyoshi, Irie, Toshiaki, Ito, Hiroshi, Suhara, Tetsuya
Publikováno v:
In Parkinsonism and Related Disorders 2010 16(6):404-408
Publikováno v:
In Comparative Biochemistry and Physiology, Part B 2010 157(1):113-118
Autor:
Uehara, Tomoya, Nakagawa, Misuzu, Takai, Nobuhiko, Koike, Sachiko, Furusawa, Yoshiya, Ando, Kouichi, Kawai, Keiichi, Akizawa, Hiromichi, Irie, Toshiaki, Arano, Yasushi
Publikováno v:
In Nuclear Medicine and Biology 2009 36(8):985-991
Autor:
Kawamura, Kazunori, Yamasaki, Tomoteru, Yui, Joji, Hatori, Akiko, Konno, Fujiko, Kumata, Katsushi, Irie, Toshiaki, Fukumura, Toshimitsu, Suzuki, Kazutoshi, Kanno, Iwao, Zhang, Ming-Rong
Publikováno v:
In Nuclear Medicine and Biology 2009 36(3):239-246
Autor:
Okamura, Toshimitsu, Igarashi, Jun, Kikuchi, Tatsuya, Fukushi, Kiyoshi, Arano, Yasushi, Irie, Toshiaki
Publikováno v:
In Life Sciences 2009 84(23):791-795
Publikováno v:
In Nuclear Medicine and Biology 2008 35(1):67-74
Autor:
Hirano, Shigeki, Shinoto, Hitoshi, Shimada, Hitoshi, Ota, Tsuneyoshi, Sato, Koichi, Tanaka, Noriko, Ming-Rong, Zhang, Higuchi, Makoto, Fukushi, Kiyoshi, Irie, Toshiaki, Kuwabara, Satoshi, Suhara, Tetsuya
Publikováno v:
Journal of Alzheimer’s Disease. 62(4):1539-1548
Background: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by chronic progressive cognitive decline and displays underlying brain cholinergic dysfunction, providing a rationale for treatment with cholinomimetic medication. T